PTGS2 and neoplasm: We here report a tumor-suppressive role of miR-146a in BRAF/MEKi-resistant melanoma and demonstrate that the manipulation of miR-146a/COX2/PGE2 axis can restore BRAF/MEKi chemosensitivity (Fig. 6).